Biotron Company Top Insiders
| BITRF Stock | USD 0.06 0.00 0.00% |
Biotron employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 115 years, averaging almost 11.0 years of service per executive, having 1.0 employees per reported executive. Examination of Biotron's management performance can provide insight into the company performance.
| Michelle Miller CEO CEO, Managing Director, Executive Director |
| Michael Hoy Chairman Independent Non-Executive Chairman of the Board |
Biotron |
Biotron Management Team Effectiveness
The company has return on total asset (ROA) of (0.5574) % which means that it has lost $0.5574 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1224) %, meaning that it generated substantial loss on money invested by shareholders. Biotron's management efficiency ratios could be used to measure how well Biotron manages its routine affairs as well as how well it operates its assets and liabilities.Biotron Workforce Comparison
Biotron Limited is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 89.0. Biotron retains roughly 10.0 in number of employees claiming about 11% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (1.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.78) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.78. Biotron Limited Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biotron Limited Price Series Summation is a cross summation of Biotron price series and its benchmark/peer.
Biotron Notable Stakeholders
A Biotron stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biotron often face trade-offs trying to please all of them. Biotron's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biotron's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michelle Miller | CEO, Managing Director, Executive Director | Profile | |
| Michael Hoy | Independent Non-Executive Chairman of the Board | Profile | |
| Robert Thomas | Independent Non-Executive Director | Profile | |
| Stephen Locarnini | Director | Profile | |
| Denis Wade | Independent Non-Executive Director | Profile | |
| Susan Pond | Independent Non-Executive Director | Profile | |
| BSc GCertAppFin | MD Director | Profile | |
| Peter Nightingale | Company Secretary | Profile | |
| CA BEcon | Company Sec | Profile | |
| Stephen MD | Chief Officer | Profile |
About Biotron Management Performance
The success or failure of an entity such as Biotron Limited often depends on how effective the management is. Biotron management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biotron management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biotron management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.
The data published in Biotron's official financial statements usually reflect Biotron's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Biotron Limited. For example, before you start analyzing numbers published by Biotron accountants, it's critical to develop an understanding of what Biotron's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Biotron's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biotron's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Biotron's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotron Limited. Please utilize our Beneish M Score to check the likelihood of Biotron's management manipulating its earnings.
Biotron Workforce Analysis
Traditionally, organizations such as Biotron use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biotron within its industry.Biotron Manpower Efficiency
Return on Biotron Manpower
| Revenue Per Employee | 155.9K | |
| Revenue Per Executive | 155.9K | |
| Net Loss Per Employee | 278.1K | |
| Net Loss Per Executive | 278.1K | |
| Working Capital Per Employee | 300K | |
| Working Capital Per Executive | 300K |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotron Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Biotron Pink Sheet analysis
When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |